114 related articles for article (PubMed ID: 3127973)
21. An aggressive, sequential combination chemotherapy regimen in the treatment of metastatic colorectal carcinoma.
Beck TM; Hart NE; Woodard DA; Smith CE
Prog Clin Biol Res; 1986; 216():399-405. PubMed ID: 3088599
[No Abstract] [Full Text] [Related]
22. Treatment of metastatic colorectal cancer with hepatic artery combination chemotherapy.
Cohen AM; Schaeffer N; Higgins J
Cancer; 1986 Mar; 57(6):1115-7. PubMed ID: 3080221
[TBL] [Abstract][Full Text] [Related]
23. Oxaliplatin and raltitrexed combined with leucovorin-modulated 5-fluorouracil i.v. bolus every two weeks: a dose finding study in advanced previously treated colorectal carcinoma. Southern Italy Cooperative Oncology Group.
Comella P; De Vita F; De Lucia L; Casaretti R; Avallone A; Orditura M; Rivellini F; Palmeri S; Catalano G; Comella G
Ann Oncol; 2000 Apr; 11(4):461-8. PubMed ID: 10847467
[TBL] [Abstract][Full Text] [Related]
24. Combination of dacarbazine and mitomycin in advanced colorectal cancer.
Bleiberg H; Clavel M; Nicaise C; Devriendt J; Michel J; Vanderlinden B; Rozencweig M
Cancer Chemother Pharmacol; 1982 Dec; 10(1):68-9. PubMed ID: 7160047
[TBL] [Abstract][Full Text] [Related]
25. Mitomycin C, teniposide, and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung.
Giaccone G; Iberti V; Donadio M; Testore F
Cancer Chemother Pharmacol; 1991; 28(2):147-9. PubMed ID: 1647895
[TBL] [Abstract][Full Text] [Related]
26. 5-Fluorouracil infusion and mitomycin combination chemotherapy in the management of patients with advanced non-small-cell lung cancer.
Weir AB; Niell HB; Griffin JP
Am J Clin Oncol; 1989 Dec; 12(6):521-3. PubMed ID: 2556013
[TBL] [Abstract][Full Text] [Related]
27. Continuous-infusion cisplatin and bolus 5-fluorouracil in colorectal carcinoma.
Posner MR; Belliveau JF; Weitberg AB; Sabbath K; Wiemann MC; Cummings FJ; Calabresi P
Cancer Treat Rep; 1987 Oct; 71(10):975-7. PubMed ID: 3308082
[TBL] [Abstract][Full Text] [Related]
28. Phase II study of sequential methotrexate and 5-FU plus mitomycin and leucovorin in patients with disseminated large bowel cancer: a Northern California Oncology Group study.
Ignoffo RJ; Friedman MA; Gribble M; Hannigan J; Reynolds R; Yu KP; Schiff S; Congdon JE
Cancer Treat Rep; 1984; 68(7-8):983-8. PubMed ID: 6611204
[TBL] [Abstract][Full Text] [Related]
29. Phase II trial of mitomycin C plus 5-FU in the treatment of drug-refractory ovarian cancer.
Alberts DS; Garcia-Kendall D; Surwit EA
Semin Oncol; 1988 Jun; 15(3 Suppl 4):22-6. PubMed ID: 3134694
[TBL] [Abstract][Full Text] [Related]
30. Intraportal chemotherapy in colorectal carcinoma as an adjuvant modality.
Metzger U; Mermillod B; Aeberhard P; Gloor F; Bissat A; Egeli R; Laffer U; Martinoli S; Mueller W; Schroeder R
World J Surg; 1987 Aug; 11(4):452-8. PubMed ID: 3114965
[No Abstract] [Full Text] [Related]
31. Activity of sequential low-dose methotrexate and fluorouracil in advanced colorectal carcinoma: attempt at correlation with tissue and blood levels of phosphoribosylpyrophosphate.
Kemeny NE; Ahmed T; Michaelson RA; Harper HD; Yip LC
J Clin Oncol; 1984 Apr; 2(4):311-5. PubMed ID: 6200577
[TBL] [Abstract][Full Text] [Related]
32. Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type.
Hasbini A; Mahjoubi R; Fandi A; Chouaki N; Taamma A; Lianes P; Cortès-Funes H; Alonso S; Armand JP; Cvitkovic E; Raymond E
Ann Oncol; 1999 Apr; 10(4):421-5. PubMed ID: 10370784
[TBL] [Abstract][Full Text] [Related]
33. [Intra-arterial chemotherapy of colorectal liver metastases with 5-fluorouracil (5-FU) and mitomycin C (MMC)].
Weder W; Roethlin M; Metzger U; Largiadèr F
Helv Chir Acta; 1987 Dec; 54(4):383-6. PubMed ID: 3128495
[No Abstract] [Full Text] [Related]
34. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.
Machover D; Goldschmidt E; Chollet P; Metzger G; Zittoun J; Marquet J; Vandenbulcke JM; Misset JL; Schwarzenberg L; Fourtillan JB
J Clin Oncol; 1986 May; 4(5):685-96. PubMed ID: 3517242
[TBL] [Abstract][Full Text] [Related]
35. Phase I/II study of first-line irinotecan combined with 5-fluorouracil and folinic acid Mayo Clinic schedule in patients with advanced colorectal cancer.
Kuehr T; Ruff P; Rapoport BL; Falk S; Daniel F; Jacobs C; Davidson N; Thaler J; Boussard B; Carmichael J
BMC Cancer; 2004 Jul; 4():36. PubMed ID: 15257756
[TBL] [Abstract][Full Text] [Related]
36. Mitomycin and methotrexate: negative experience in untreated colorectal carcinoma.
Wernz JC; Kao AK; Muggia FM; Asbury RF
Cancer Treat Rep; 1985 Feb; 69(2):223-4. PubMed ID: 3918793
[No Abstract] [Full Text] [Related]
37. Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer.
Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Tixi LM; Bolli EA; Rosso R; Mammoliti S; Rollandi GA; Bertoglio S
Clin Cancer Res; 1995 Sep; 1(9):955-60. PubMed ID: 9816066
[TBL] [Abstract][Full Text] [Related]
38. Sequential methotrexate plus 5-FU in advanced breast and colorectal cancers: a phase II study.
Kaye SB; Sangster G; Hutcheon A; Habeshaw T; Crossling F; Ferguson C; McArdle C; Smith D; George WD; Calman KC
Cancer Treat Rep; 1984 Mar; 68(3):547-8. PubMed ID: 6704984
[TBL] [Abstract][Full Text] [Related]
39. Cisplatin and 5-fluorouracil combination chemotherapy in advanced and/or metastatic colorectal carcinoma: a phase II study.
Galligioni E; Canobbio L; Figoli F; Fassio T; Frustaci S; Crivellari D; Vaccher E; Lo Re G; Gasparini G; Veronesi A
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):657-61. PubMed ID: 3653187
[TBL] [Abstract][Full Text] [Related]
40. 5-Fluorouracil, high-dose folinic acid and mitomycin C combination chemotherapy in previously treated patients with advanced colorectal carcinoma.
Seitz JF; Perrier H; Giovannini M; Capodano G; Bernardini D; Bardou VJ
J Chemother; 1998 Jun; 10(3):258-65. PubMed ID: 9669654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
